Coming off a recent $139 million initial public offering of stock, Ultragenyx Pharmaceutical, Inc., (Nasdaq:RARE) is doubling the size of its headquarters as it enters latter stages of research and development of some of its treatments for rare diseases. Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) shares after opening at $51.88 moved to $52.22 on last trade day and at the end of the day closed at $50.67. Price to cash ratio as 23.93. Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) showed a positive weekly performance of 10.90%.
Depomed Inc (NASDAQ:DEPO) had its price target raised by Roth Capital from $12.50 to $14.00. Depomed Inc (NASDAQ:DEPO) shares fell -2.22% in last trading session and ended the day on $13.21. DEPO return on equity ratio is recorded as 44.10% and its return on assets is 18.50%. Depomed Inc (NASDAQ:DEPO) yearly performance is 143.28%.
Career Education Corp. (NASDAQ:CECO) announced that it is uniting the educational mission of International Academy of Design and Technology (IADT), Brown College and Sanford-Brown to create comprehensive career schools under the Sanford-Brown name. Career Education Corp. (NASDAQ:CECO) shares moved down -1.30% in last trading session and was closed at $7.24, while trading in range of $6.87-$7.64. Career Education Corp. (NASDAQ:CECO) year to date performance is 26.93%.
Agios Pharmaceuticals (NASDAQ:AGIO) Insider Scott Biller unloaded 4,500 shares of Agios Pharmaceuticals stock on the open market in a transaction that occurred on Tuesday, April 1st. The shares were sold at an average price of $38.08, for a total value of $171,360.00. Following the completion of the transaction, the insider now directly owns 30,000 shares in the company, valued at approximately $1,142,400. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Agios Pharmaceuticals Inc (NASDAQ:AGIO) weekly performance is -4.16%. On last trading day company shares ended up $35.48. Agios Pharmaceuticals Inc (NASDAQ:AGIO) distance from 50-day simple moving average is 2.43%. Analysts mean target price for the company is $49.00.
Leave a Reply